Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries.

Whelan DM, van der Giessen WJ, Krabbendam SC, van Vliet EA, Verdouw PD, Serruys PW, van Beusekom HM.

Heart. 2000 Mar;83(3):338-45.

2.

Phosphorylcholine-coated stents in porcine coronary arteries: in vivo assessment of biocompatibility.

Malik N, Gunn J, Shepherd L, Crossman DC, Cumberland DC, Holt CM.

J Invasive Cardiol. 2001 Mar;13(3):193-201.

PMID:
11231644
3.

Addition of cytochalasin D to a biocompatible oil stent coating inhibits intimal hyperplasia in a porcine coronary model.

Salu KJ, Huang Y, Bosmans JM, Liu X, Li S, Wang L, Verbeken E, Bult H, Vrints CJ, De Scheerder IK.

Coron Artery Dis. 2003 Dec;14(8):545-55.

PMID:
14646676
4.
5.

Drug loading and elution from a phosphorylcholine polymer-coated coronary stent does not affect long-term stability of the coating in vivo.

Lewis AL, Willis SL, Small SA, Hunt SR, O'byrne V, Stratford PW.

Biomed Mater Eng. 2004;14(4):355-70.

PMID:
15472385
6.

Analysis of a phosphorylcholine-based polymer coating on a coronary stent pre- and post-implantation.

Lewis AL, Tolhurst LA, Stratford PW.

Biomaterials. 2002 Apr;23(7):1697-706.

PMID:
11922473
7.

Long-term biocompatibility evaluation of a novel polymer-coated stent in a porcine coronary stent model.

Huang Y, Liu X, Wang L, Li S, Verbeken E, De Scheerder I.

Coron Artery Dis. 2003 Aug;14(5):401-8.

PMID:
12878906
8.

Angiopeptin-eluting stents: observations in human vessels and pig coronary arteries.

Armstrong J, Gunn J, Arnold N, Malik N, Chan KH, Vick T, Stratford P, Cumberland DC, Holt CM.

J Invasive Cardiol. 2002 May;14(5):230-8.

PMID:
11983942
9.

Stent-based delivery of ABT-578 via a phosphorylcholine surface coating reduces neointimal formation in the porcine coronary model.

Collingwood R, Gibson L, Sedlik S, Virmani R, Carter AJ.

Catheter Cardiovasc Interv. 2005 Jun;65(2):227-32.

PMID:
15900559
10.

Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries.

Hårdhammar PA, van Beusekom HM, Emanuelsson HU, Hofma SH, Albertsson PA, Verdouw PD, Boersma E, Serruys PW, van der Giessen WJ.

Circulation. 1996 Feb 1;93(3):423-30.

11.

Biocompatibility of tetramethylpyrazine-eluting stents in normal porcine coronary arteries.

Ma GS, Chen LJ, Chen Z, Ding S, Shen CX, Feng Y.

Biomed Pharmacother. 2008 Feb;62(2):125-9. Epub 2007 Aug 10.

PMID:
17764890
12.

Biomimicry 1: PC.

Cumberland DC, Gunn J, Malik N, Holt CM.

Semin Interv Cardiol. 1998 Sep-Dec;3(3-4):149-50. Review.

PMID:
10406685
13.

Local methylprednisolone inhibition of foreign body response to coated intracoronary stents.

de Scheerder I, Wang K, Wilczek K, van Dorpe J, Verbeken E, Desmet W, Schacht E, Piessens J.

Coron Artery Dis. 1996 Feb;7(2):161-6.

PMID:
8813449
14.

A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.

Bhargava B, Reddy NK, Karthikeyan G, Raju R, Mishra S, Singh S, Waksman R, Virmani R, Somaraju B.

Catheter Cardiovasc Interv. 2006 May;67(5):698-702.

PMID:
16575925
15.

Vascular delivery of c-myc antisense from cationically modified phosphorylcholine coated stents.

Chan KH, Armstrong J, Withers S, Malik N, Cumberland DC, Gunn J, Holt CM.

Biomaterials. 2007 Feb;28(6):1218-24.

PMID:
17126396
16.

Stent-based tempamine delivery on neointimal formation in a porcine coronary model.

Huang Y, Wang L, Li S, Liu X, Lee K, Verbeken E, van de Werf F, de Scheerder I.

Acute Card Care. 2006;8(4):210-6.

PMID:
17162547
17.

A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.

Blindt R, Vogt F, Astafieva I, Fach C, Hristov M, Krott N, Seitz B, Kapurniotu A, Kwok C, Dewor M, Bosserhoff AK, Bernhagen J, Hanrath P, Hoffmann R, Weber C.

J Am Coll Cardiol. 2006 May 2;47(9):1786-95. Epub 2006 Apr 19.

18.

Estrogen-eluting, phosphorylcholine-coated stent implantation is associated with reduced neointimal formation but no delay in vascular repair in a porcine coronary model.

New G, Moses JW, Roubin GS, Leon MB, Colombo A, Iyer SS, Tio FO, Mehran R, Kipshidze N.

Catheter Cardiovasc Interv. 2002 Oct;57(2):266-71.

PMID:
12357534
19.

New biocompatible polymer surface coating for stents results in a low neointimal response.

Bär FW, van der Veen FH, Benzina A, Habets J, Koole LH.

J Biomed Mater Res. 2000 Oct;52(1):193-8.

PMID:
10906692
20.

Tyrphostin AGL-2043 eluting stent reduces neointima formation in porcine coronary arteries.

Banai S, Gertz SD, Gavish L, Chorny M, Perez LS, Lazarovichi G, Ianculuvich M, Hoffmann M, Orlowski M, Golomb G, Levitzki A.

Cardiovasc Res. 2004 Oct 1;64(1):165-71.

PMID:
15364624

Supplemental Content

Support Center